OHB's Index Ascent Collides With a Sector-Wide De-Rating

OHB's shares fall 71% from May high amid SpaceX-linked sell-off, despite solid H1 results and record order book.

The timing could hardly have been more awkward. Barely a fortnight after STOXX handed OHB a coveted SDAX slot on 13 August — replacing Klöckner & Co in the German small-cap benchmark — the Bremen-based space group has found itself at the sharp end of a five-session losing streak that ended with the stock propping up the entire index.

For a company that had spent the past year cementing its reputation as one of Germany's most striking growth stories, the whiplash has been severe. The shares now change hands at €198.20, a full 71 percent below the 52-week peak of €688.00 touched in May. The seven-day decline alone stands at 22 percent, a slide that has left even the most patient holders questioning whether the sell-off has run its course.

A Correction With a Familiar Catalyst

What makes the current drawdown particularly galling for OHB investors is that the operational picture has, by most measures, remained intact. The company confirmed its 2026 guidance in early August — total output of €1.4 billion at an adjusted EBITDA margin of 10.5 to 11 percent — and delivered first-half numbers that showed profitable growth alongside a flurry of new partnerships.

The fundamentals, in other words, have not deteriorated. What has changed is the mood music around the broader space sector. The May rally that carried OHB to its record high was, in large part, a sympathy move tied to the SpaceX initial public offering. That benchmark has since become a liability: SpaceX itself has slipped below its issue price after peaking in mid-June, dragging the entire complex down with it. What began as shared euphoria is now playing out as a shared correction.

The numbers underscore the disconnect. OHB's first-half total output came in at €628 million, with adjusted EBITDA of €60 million — up more than 30 percent year on year. The order book sits at a record high, and management points to a pipeline of roughly €20 billion in potential new projects. Add to that the Handelsblatt-reported award of a €1 billion contract for 18 satellites under the EU's Iris2 programme, plus the PRISMA second-generation mission secured by OHB Italia from the Italian space agency ASI in late July, and the bull case writes itself.

When Good News Stops Traveling

Yet the market has been singularly unimpressed. Both the SDAX inclusion and the Iris2 news sparked only brief bounces before the gains were swiftly surrendered — a pattern that suggests positive headlines are currently finding little traction. The stock now trades roughly 27 percent below its 50-day moving average, a technical signal that the near-term trend remains firmly southward.

Analysts, for their part, have begun to stick their necks out. Several published first-time price targets in early August ranging from €250 to €360 — comfortably above the current level. The gap between those figures and the prevailing share price could, in a calmer tape, lure bargain hunters back in.

The question is whether OHB can decouple from the SpaceX-driven sentiment that has governed its trajectory since the spring. The two names have moved in near lockstep for months, and until that correlation breaks, the German group remains hostage to a sector-wide de-rating that has little to do with its own execution.

A Structural Tailwind, For What It's Worth

The SDAX promotion itself is not without consequence. Index inclusion typically forces passive funds and institutional mandates to build positions, creating a structural bid that outlasts any single news cycle. A further step up — market observers already point to a regular STOXX review in September 2026 as the likely window for a TecDAX promotion — would amplify that effect.

Whether such flows prove sufficient to reverse the chart damage is another matter. The stock's 190 percent gain over the past twelve months left it vulnerable to exactly this kind of violent mean-reversion, and momentum unwinds of this magnitude rarely turn on a single catalyst.

The near-term risk is straightforward: if guidance were to slip — through delays on marquee projects such as Iris2 or PRISMA, for instance — the fundamental narrative itself would crack, validating the sellers. Barring that, the current weakness reads less as an operational crisis and more as a valuation reset following a speculative surge. The watch item for investors remains SpaceX, whose own trajectory will likely continue to set the tone for OHB's share price irrespective of the Bremen group's order intake. The more telling signal will come when positive company-specific news starts holding its gains — something that has been conspicuously absent in recent weeks.